These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26131063)

  • 1. Bone fracture and the interaction between bisphosphonates and proton pump inhibitors: a meta-analysis.
    Yang SD; Chen Q; Wei HK; Zhang F; Yang DL; Shen Y; Ding WY
    Int J Clin Exp Med; 2015; 8(4):4899-910. PubMed ID: 26131063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis: risk of fractures with acid-suppressing medication.
    Kwok CS; Yeong JK; Loke YK
    Bone; 2011 Apr; 48(4):768-76. PubMed ID: 21185417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton-pump inhibitors and risk of fractures: an update meta-analysis.
    Zhou B; Huang Y; Li H; Sun W; Liu J
    Osteoporos Int; 2016 Jan; 27(1):339-47. PubMed ID: 26462494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitors therapy and risk of bone diseases: An update meta-analysis.
    Liu J; Li X; Fan L; Yang J; Wang J; Sun J; Wang Z
    Life Sci; 2019 Feb; 218():213-223. PubMed ID: 30605646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies.
    Ngamruengphong S; Leontiadis GI; Radhi S; Dentino A; Nugent K
    Am J Gastroenterol; 2011 Jul; 106(7):1209-18; quiz 1219. PubMed ID: 21483462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acid-Suppressive Drugs and Risk of Fracture in Children and Young Adults: A Meta-Analysis of Observational Studies.
    Li J; Xie X; Liu W; Gu F; Zhang K; Su Z; Wen Q; Sui Z; Zhou P; Yu T
    Front Pharmacol; 2021; 12():712939. PubMed ID: 34421609
    [No Abstract]   [Full Text] [Related]  

  • 7. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis.
    Trifan A; Stanciu C; Girleanu I; Stoica OC; Singeap AM; Maxim R; Chiriac SA; Ciobica A; Boiculese L
    World J Gastroenterol; 2017 Sep; 23(35):6500-6515. PubMed ID: 29085200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
    Lin SM; Yang SH; Liang CC; Huang HK
    Osteoporos Int; 2018 Jan; 29(1):153-162. PubMed ID: 29032384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitors' use and risk of hip fracture: a systematic review and meta-analysis.
    Hussain S; Siddiqui AN; Habib A; Hussain MS; Najmi AK
    Rheumatol Int; 2018 Nov; 38(11):1999-2014. PubMed ID: 30159775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors therapy and risk of hip fracture: a systematic review and meta-analysis.
    Ye X; Liu H; Wu C; Qin Y; Zang J; Gao Q; Zhang X; He J
    Eur J Gastroenterol Hepatol; 2011 Sep; 23(9):794-800. PubMed ID: 21701389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates in multiple myeloma: a network meta-analysis.
    Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
    Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies.
    Yang Y; George KC; Shang WF; Zeng R; Ge SW; Xu G
    Drug Des Devel Ther; 2017; 11():1291-1299. PubMed ID: 28479851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis.
    Kwok CS; Jeevanantham V; Dawn B; Loke YK
    Int J Cardiol; 2013 Aug; 167(3):965-74. PubMed ID: 22464478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis.
    Park CH; Kim EH; Roh YH; Kim HY; Lee SK
    PLoS One; 2014; 9(11):e112558. PubMed ID: 25394217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Bisphosphonates Prevent Recurrent Fragility Fractures? A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Lee SY; Jung SH; Lee SU; Ha YC; Lim JY
    J Am Med Dir Assoc; 2018 May; 19(5):384-390.e1. PubMed ID: 29704927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between Proton Pump Inhibitors and Adverse Effects in Hemodialysis Patients: A Systematic Review and Meta-Analysis.
    Zhang Y; Deng D; Zhang R; Yi J; Dong J; Sha L
    Kidney Blood Press Res; 2022; 47(9):545-555. PubMed ID: 35878597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study.
    van der Hoorn MMC; Tett SE; de Vries OJ; Dobson AJ; Peeters GMEEG
    Bone; 2015 Dec; 81():675-682. PubMed ID: 26319499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitor treatment for acute peptic ulcer bleeding.
    Leontiadis GI; Sharma VK; Howden CW
    Cochrane Database Syst Rev; 2006 Jan; (1):CD002094. PubMed ID: 16437441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between proton-pump inhibitors and the risk of gastric cancer: a systematic review and meta-analysis.
    Peng TR; Wu TW; Li CH
    Int J Clin Oncol; 2023 Jan; 28(1):99-109. PubMed ID: 36224477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of proton pump inhibitors with risk of hepatic encephalopathy in advanced liver disease: A meta-analysis.
    Tantai XX; Yang LB; Wei ZC; Xiao CL; Chen LR; Wang JH; Liu N
    World J Gastroenterol; 2019 Jun; 25(21):2683-2698. PubMed ID: 31210719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.